Search alternatives:
significant processes » significant progress (Expand Search), significant promise (Expand Search), significant increases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
processes decrease » progressive decrease (Expand Search)
significant processes » significant progress (Expand Search), significant promise (Expand Search), significant increases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
processes decrease » progressive decrease (Expand Search)
-
481
-
482
-
483
-
484
-
485
-
486
-
487
-
488
-
489
-
490
Quantitative analysis.
Published 2024“…ELISA results revealed that the levels of key inflammatory cytokines (TNF-α, IL-1β, IL-17 and IL-23) were significantly elevated in the LPS-treated model group (<i>P</i><0.0001, <i>P</i><0.001), but these levels were significantly decreased after NMRAL1 siRNA transfection (<i>P</i><0.0001, <i>P</i><0.01, <i>P</i><0.05).…”
-
491
-
492
-
493
<i>Shroom3</i> myocardial specific loss does not alter postnatal cardiac morphology.
Published 2025Subjects: -
494
-
495
Myocardial <i>Shroom3</i> loss during development does not show abnormal semilunar valves.
Published 2025Subjects: -
496
-
497
-
498
Myocardial <i>Shroom3</i> loss during development does not show ventricular septal defects.
Published 2025Subjects: -
499
-
500
Myocardial <i>Shroom3</i> loss during development does not alter ventricular wall thickness.
Published 2025Subjects: